<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35857271</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-0100</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Endocrine</Title><ISOAbbreviation>Endocrine</ISOAbbreviation></Journal><ArticleTitle>The osteo-metabolic phenotype of COVID-19: an update.</ArticleTitle><Pagination><StartPage>247</StartPage><EndPage>254</EndPage><MedlinePgn>247-254</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12020-022-03135-3</ELocationID><Abstract><AbstractText Label="CONTEXT">In the multifaceted COVID-19 clinical scenario characterized by a multi-system disorder with negative implications not only on respiratory function but also on cardiac, hematological, neurological and endocrine-metabolic systems, a distinctive osteo-metabolic phenotype with an independent influence on disease severity and recovery of patients affected was early reported.</AbstractText><AbstractText Label="AIM">To summarize and update the main evidences regarding the distinct components of this phenotype in acute and Long COVID-19, reinforcing its clinical relevance and discussing the main pathophysiological and clinical-therapeutic implications of the most recent reported findings.</AbstractText><AbstractText Label="RESULTS">This emerging phenotype is characterized by a widespread acute hypocalcemia and hypovitaminosis D with an impaired compensatory parathyroid hormone response, and a high prevalence of skeletal complications such as vertebral fractures. The clinical relevance of this osteo-metabolic phenotype on acute COVID-19 is well characterized, and novel seminal evidences are progressively highlighting its importance also in predicting patient's long-term outcomes and Long COVID-19 occurrence.</AbstractText><AbstractText Label="CONCLUSIONS">These findings reinforced the central role of a multidisciplinary team, including endocrinologists, in evaluating these patients for a proactive search of each aspect of the osteo-metabolic phenotype components since they may represent suitable therapeutic targets to prevent SARS-CoV-2 infection, poor COVID-19 outcomes, Long COVID-19 occurrence and even possibly better responses to COVID-19 vaccination.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>di Filippo</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Endocrine and Metabolic Sciences, Universit&#xe0; Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frara</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Endocrine and Metabolic Sciences, Universit&#xe0; Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doga</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Endocrine and Metabolic Sciences, Universit&#xe0; Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giustina</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6783-3398</Identifier><AffiliationInfo><Affiliation>Institute of Endocrine and Metabolic Sciences, Universit&#xe0; Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy. giustina.andrea@hsr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Endocrine</MedlineTA><NlmUniqueID>9434444</NlmUniqueID><ISSNLinking>1355-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010281">Parathyroid Hormone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010281" MajorTopicYN="N">Parathyroid Hormone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Hypocalcemia</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Osteo-metabolic phenotype</Keyword><Keyword MajorTopicYN="N">Vertebral fractures</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>20</Day><Hour>11</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35857271</ArticleId><ArticleId IdType="pmc">PMC9297261</ArticleId><ArticleId IdType="doi">10.1007/s12020-022-03135-3</ArticleId><ArticleId IdType="pii">10.1007/s12020-022-03135-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26(7):1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Puig-Domingo M, Marazuela M, Giustina A. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine. 2020;68(1):2&#x2013;5. doi: 10.1007/s12020-020-02294-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02294-5</ArticleId><ArticleId IdType="pmc">PMC7150529</ArticleId><ArticleId IdType="pubmed">32279224</ArticleId></ArticleIdList></Reference><Reference><Citation>Puig-Domingo M, Marazuela M, Yildiz BO, Giustina A. COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology. Endocrine. 2021;72(2):301&#x2013;316. doi: 10.1007/s12020-021-02734-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02734-w</ArticleId><ArticleId IdType="pmc">PMC8105151</ArticleId><ArticleId IdType="pubmed">33963516</ArticleId></ArticleIdList></Reference><Reference><Citation>Marazuela M, Giustina A, Puig-Domingo M. Endocrine and metabolic aspects of the COVID-19 pandemic [published correction appears in Rev Endocr Metab Disord. 2021 Mar;22(1):145] Rev. Endocr. Metab. Disord. 2020;21(4):495&#x2013;507. doi: 10.1007/s11154-020-09569-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-020-09569-2</ArticleId><ArticleId IdType="pmc">PMC7343578</ArticleId><ArticleId IdType="pubmed">32643004</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A, Bilezikian JP. Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic. Rev. Endocr. Metab. Disord. 2022;23(2):133&#x2013;136. doi: 10.1007/s11154-022-09716-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-022-09716-x</ArticleId><ArticleId IdType="pmc">PMC8857394</ArticleId><ArticleId IdType="pubmed">35182326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19) Diabetes Metab. Res. Rev. 2021;37(2):e3377. doi: 10.1002/dmrr.3377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3377</ArticleId><ArticleId IdType="pmc">PMC7361201</ArticleId><ArticleId IdType="pubmed">32588943</ArticleId></ArticleIdList></Reference><Reference><Citation>Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev. Endocr. Metab. Disord. 2021;22(4):803&#x2013;815. doi: 10.1007/s11154-020-09615-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-020-09615-z</ArticleId><ArticleId IdType="pmc">PMC7688298</ArticleId><ArticleId IdType="pubmed">33241508</ArticleId></ArticleIdList></Reference><Reference><Citation>Frara S, Allora A, Castellino L, di Filippo L, Loli P, Giustina A. COVID-19 and the pituitary. Pituitary. 2021;24(3):465&#x2013;481. doi: 10.1007/s11102-021-01148-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11102-021-01148-1</ArticleId><ArticleId IdType="pmc">PMC8089131</ArticleId><ArticleId IdType="pubmed">33939057</ArticleId></ArticleIdList></Reference><Reference><Citation>Frara S, Loli P, Allora A, et al. COVID-19 and hypopituitarism. Rev. Endocr. Metab. Disord. 2022;23(2):215&#x2013;231. doi: 10.1007/s11154-021-09672-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09672-y</ArticleId><ArticleId IdType="pmc">PMC8363093</ArticleId><ArticleId IdType="pubmed">34387832</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Frara S, Giustina A. The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects. Nat. Rev. Endocrinol. 2021;17(8):445&#x2013;446. doi: 10.1038/s41574-021-00516-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-021-00516-y</ArticleId><ArticleId IdType="pmc">PMC8170860</ArticleId><ArticleId IdType="pubmed">34079100</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossoni S, Chiesa L, Giustina A. Severe hypocalcemia in a thyroidectomized woman with Covid-19 infection. Endocrine. 2020;68(2):253&#x2013;254. doi: 10.1007/s12020-020-02326-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02326-0</ArticleId><ArticleId IdType="pmc">PMC7188455</ArticleId><ArticleId IdType="pubmed">32346814</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Doga M, Frara S, Giustina A. Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications. Rev. Endocr. Metab. Disord. 2022;23(2):299&#x2013;308. doi: 10.1007/s11154-021-09655-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09655-z</ArticleId><ArticleId IdType="pmc">PMC8041474</ArticleId><ArticleId IdType="pubmed">33846867</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo L, Formenti AM, Rovere-Querini P, et al. Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19. Endocrine. 2020;68(3):475&#x2013;478. doi: 10.1007/s12020-020-02383-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02383-5</ArticleId><ArticleId IdType="pmc">PMC7292572</ArticleId><ArticleId IdType="pubmed">32533508</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Han P, Wu J, Gong J, Tian D. Prevalence and predictive value of hypocalcemia in severe COVID-19 patients. J. Infect. Public Health. 2020;13(9):1224&#x2013;1228. doi: 10.1016/j.jiph.2020.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.05.029</ArticleId><ArticleId IdType="pmc">PMC7306733</ArticleId><ArticleId IdType="pubmed">32622796</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun JK, Zhang WH, Zou L, et al. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019. Aging (Albany NY) 2020;12(12):11287&#x2013;11295. doi: 10.18632/aging.103526.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103526</ArticleId><ArticleId IdType="pmc">PMC7343468</ArticleId><ArticleId IdType="pubmed">32589164</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Formenti AM, Doga M, et al. Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients. Endocrine. 2021;71(1):9&#x2013;13. doi: 10.1007/s12020-020-02541-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02541-9</ArticleId><ArticleId IdType="pmc">PMC7649576</ArticleId><ArticleId IdType="pubmed">33165763</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta M, Ghani H, Chua F, et al. Retrospective case-control study to evaluate hypocalcaemia as a distinguishing feature of COVID-19 compared with other infective pneumonias and its association with disease severity. BMJ Open. 2021;11(12):e053810. doi: 10.1136/bmjopen-2021-053810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-053810</ArticleId><ArticleId IdType="pmc">PMC8655344</ArticleId><ArticleId IdType="pubmed">34876435</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R, Ram S, Zohmangaihi D, et al. High prevalence of hypocalcemia in non-severe COVID-19 patients: a retrospective case-control study. Front. Med. (Lausanne) 2021;7:590805. doi: 10.3389/fmed.2020.590805.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.590805</ArticleId><ArticleId IdType="pmc">PMC7817940</ArticleId><ArticleId IdType="pubmed">33490095</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemzadeh E, Alemzadeh E, Ziaee M, Abedi A, Salehiniya H. The effect of low serum calcium level on the severity and mortality of Covid patients: a systematic review and meta-analysis. Immun. Inflamm. Dis. 2021;9(4):1219&#x2013;1228. doi: 10.1002/iid3.528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.528</ArticleId><ArticleId IdType="pmc">PMC8589360</ArticleId><ArticleId IdType="pubmed">34534417</ArticleId></ArticleIdList></Reference><Reference><Citation>Martha JW, Wibowo A, Pranata R. Hypocalcemia is associated with severe COVID-19: a systematic review and meta-analysis. Diabetes Metab. Syndr. 2021;15(1):337&#x2013;342. doi: 10.1016/j.dsx.2021.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.01.003</ArticleId><ArticleId IdType="pmc">PMC7832827</ArticleId><ArticleId IdType="pubmed">33493853</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Formenti AM, Giustina A. Hypocalcemia: the quest for the cause of a major biochemical feature of COVID-19. Endocrine. 2020;70(3):463&#x2013;464. doi: 10.1007/s12020-020-02525-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02525-9</ArticleId><ArticleId IdType="pmc">PMC7580813</ArticleId><ArticleId IdType="pubmed">33094473</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Frey TK, Yang JJ. Viral calciomics: interplays between Ca2+ and virus. Cell Calcium. 2009;46(1):1&#x2013;17. doi: 10.1016/j.ceca.2009.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2009.05.005</ArticleId><ArticleId IdType="pmc">PMC3449087</ArticleId><ArticleId IdType="pubmed">19535138</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlansky S, Sallinger M, Grabmayr H, et al. Calcium signals during SARS-CoV-2 infection: assessing the potential of emerging therapies. Cells. 2022;11(2):253. doi: 10.3390/cells11020253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11020253</ArticleId><ArticleId IdType="pmc">PMC8773957</ArticleId><ArticleId IdType="pubmed">35053369</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavezzi A, Menicagli R, Troiani E, Corrao S. COVID-19, cation dysmetabolism, sialic acid, CD147, ACE2, viroporins, hepcidin and ferroptosis: a possible unifying hypothesis. F1000Res. 2022;11:102. doi: 10.12688/f1000research.108667.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.108667.2</ArticleId><ArticleId IdType="pmc">PMC8921693</ArticleId><ArticleId IdType="pubmed">35340277</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Autopsy Electronic address: anapat.hrc@salud.madrid.org. The first COVID-19 autopsy in Spain performed during the early stages of the pandemic. Rev. Esp. Patol. 2020;53(3):182&#x2013;187. doi: 10.1016/j.patol.2020.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.patol.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7245282</ArticleId><ArticleId IdType="pubmed">32650969</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalbhenn J, Knoerlein J. Intramuscular deposit of calcium is a potential reason for hypocalcaemia in COVID-19. Endocrine. 2021;72(1):24&#x2013;26. doi: 10.1007/s12020-021-02708-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02708-y</ArticleId><ArticleId IdType="pmc">PMC8027705</ArticleId><ArticleId IdType="pubmed">33830438</ArticleId></ArticleIdList></Reference><Reference><Citation>Brass EP, Forman WB, Edwards RV, Lindan O. Fibrin formation: effect of calcium ions. Blood. 1978;52(4):654&#x2013;658. doi: 10.1182/blood.V52.4.654.654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V52.4.654.654</ArticleId><ArticleId IdType="pubmed">687825</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi X, Kong H, Ding W, et al. Abnormal coagulation function of patients with COVID-19 is significantly related to hypocalcemia and severe inflammation. Front. Med. (Lausanne) 2021;8:638194. doi: 10.3389/fmed.2021.638194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.638194</ArticleId><ArticleId IdType="pmc">PMC8242574</ArticleId><ArticleId IdType="pubmed">34222271</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo L, De Lorenzo R, D&#x2019;Amico M, et al. COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: a post-hoc analysis of a prospective cohort study. Clin. Nutr. 2021;40(4):2420&#x2013;2426. doi: 10.1016/j.clnu.2020.10.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.10.043</ArticleId><ArticleId IdType="pmc">PMC7598735</ArticleId><ArticleId IdType="pubmed">33160700</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh VP, Khatua B, El-Kurdi B, Rood C. Mechanistic basis and therapeutic relevance of hypocalcemia during severe COVID-19 infection. Endocrine. 2020;70(3):461&#x2013;462. doi: 10.1007/s12020-020-02530-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02530-y</ArticleId><ArticleId IdType="pmc">PMC7585352</ArticleId><ArticleId IdType="pubmed">33099749</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Allora A, Locatelli M, et al. Hypocalcemia in COVID-19 is associated with low vitamin D levels and impaired compensatory PTH response. Endocrine. 2021;74(2):219&#x2013;225. doi: 10.1007/s12020-021-02882-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02882-z</ArticleId><ArticleId IdType="pmc">PMC8480127</ArticleId><ArticleId IdType="pubmed">34586582</ArticleId></ArticleIdList></Reference><Reference><Citation>A. Linglart, A.S. Lambert, Approach to patient with severe hypocalcaemia. In Oxford Textbook of Clinical Nephrology, 4th edn, ch. 38, pp 378&#x2013;383. N. Turner, N. Lameire, D. Goldsmith, C. Winearls, J. Himmelfarb &amp; G. Remuzzi, Eds New York, NY: Oxford University Press, 2015</Citation></Reference><Reference><Citation>Gittoes NJ, Criseno S, Appelman-Dijkstra NM, et al. Endocrinology in the time of COVID-19: Management of calcium metabolic disorders and osteoporosis. Eur. J. Endocrinol. 2020;183(2):G57&#x2013;G65. doi: 10.1530/EJE-20-0385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0385</ArticleId><ArticleId IdType="pmc">PMC7938011</ArticleId><ArticleId IdType="pubmed">32396134</ArticleId></ArticleIdList></Reference><Reference><Citation>Tecilazich F, Formenti AM, Frara S, Giubbini R, Giustina A. Treatment of hypoparathyroidism. Best. Pr. Res Clin. Endocrinol. Metab. 2018;32(6):955&#x2013;964. doi: 10.1016/j.beem.2018.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2018.12.002</ArticleId><ArticleId IdType="pubmed">30551988</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameil MA, Marzouk RE, Elsebaie AH, Rozaik SE. Long-term clinical and biochemical residue after COVID-19 recovery. Egypt Liver J. 2021;11(1):74. doi: 10.1186/s43066-021-00144-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43066-021-00144-1</ArticleId><ArticleId IdType="pmc">PMC8435147</ArticleId><ArticleId IdType="pubmed">34777873</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R, Joshi A, Bhadada SK, Banerjee M, Vaikkakara S, Mukhopadhyay S. Endocrine follow-up during post-acute COVID-19: Practical recommendations based on available clinical evidence. Endocr. Pr. 2022;28(4):425&#x2013;432. doi: 10.1016/j.eprac.2022.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8832848</ArticleId><ArticleId IdType="pubmed">35158058</ArticleId></ArticleIdList></Reference><Reference><Citation>A. Giustina, A.M. Formenti (2020) Does hypovitaminosis D play a role in the high impact of COVID infection in Italy? British Medical Journal Available at: https://www.bmj.com/content/368/bmj.m810/rr-36</Citation></Reference><Reference><Citation>Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr. Rev. 2019;40(4):1109&#x2013;1151. doi: 10.1210/er.2018-00126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2018-00126</ArticleId><ArticleId IdType="pmc">PMC6626501</ArticleId><ArticleId IdType="pubmed">30321335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP, Bikle D, Hewison M, et al. Mechanisms in endocrinology: vitamin D and COVID-19. Eur. J. Endocrinol. 2020;183(5):R133&#x2013;R147. doi: 10.1530/EJE-20-0665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0665</ArticleId><ArticleId IdType="pmc">PMC9494342</ArticleId><ArticleId IdType="pubmed">32755992</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenngam N, Holick MF. Immunologic effects of vitamin D on human health and disease. Nutrients. 2020;12(7):2097. doi: 10.3390/nu12072097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12072097</ArticleId><ArticleId IdType="pmc">PMC7400911</ArticleId><ArticleId IdType="pubmed">32679784</ArticleId></ArticleIdList></Reference><Reference><Citation>Dissanayake HA, de Silva NL, Sumanatilleke M, et al. Prognostic and therapeutic role of vitamin D in COVID-19: systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2022;107(5):1484&#x2013;1502. doi: 10.1210/clinem/dgab892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab892</ArticleId><ArticleId IdType="pmc">PMC8689831</ArticleId><ArticleId IdType="pubmed">34894254</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopefl R, Ben-Eltriki M, Deb S. Association between vitamin D levels and inflammatory markers in COVID-19 patients: a meta-analysis of observational studies. J. Pharm. Pharm. Sci. 2022;25:124&#x2013;136. doi: 10.18433/jpps32518.</Citation><ArticleIdList><ArticleId IdType="doi">10.18433/jpps32518</ArticleId><ArticleId IdType="pubmed">35379386</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiodini I, Gatti D, Soranna D, et al. Vitamin D status and SARS-CoV-2 infection and COVID-19 clinical outcomes. Front Public Health. 2021;9:736665. doi: 10.3389/fpubh.2021.736665.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.736665</ArticleId><ArticleId IdType="pmc">PMC8727532</ArticleId><ArticleId IdType="pubmed">35004568</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbar MR, Wibowo A, Pranata R, Setiabudiawan B. Low Serum 25-hydroxyvitamin D (Vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: a systematic review and meta-analysis [published correction appears in Front Nutr. 2021 Sep 27;8:754539] Front Nutr. 2021;8:660420. doi: 10.3389/fnut.2021.660420.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.660420</ArticleId><ArticleId IdType="pmc">PMC8039288</ArticleId><ArticleId IdType="pubmed">33855042</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A, Adler RA, Binkley N, et al. Controversies in vitamin D: summary statement from an international conference. J. Clin. Endocrinol. Metab. 2019;104(2):234&#x2013;240. doi: 10.1210/jc.2018-01414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2018-01414</ArticleId><ArticleId IdType="pubmed">30383226</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A, Adler RA, Binkley N, et al. Consensus statement from 2nd International Conference on Controversies in Vitamin D. Rev. Endocr. Metab. Disord. 2020;21(1):89&#x2013;116. doi: 10.1007/s11154-019-09532-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-019-09532-w</ArticleId><ArticleId IdType="pmc">PMC7113202</ArticleId><ArticleId IdType="pubmed">32180081</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandi ML, Giustina A. Sexual dimorphism of coronavirus 19 morbidity and lethality. Trends Endocrinol. Metab. 2020;31(12):918&#x2013;927. doi: 10.1016/j.tem.2020.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2020.09.003</ArticleId><ArticleId IdType="pmc">PMC7513816</ArticleId><ArticleId IdType="pubmed">33082024</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddaloni E, Cavallari I, Napoli N, Conte C. Vitamin D and diabetes mellitus. Front Horm. Res. 2018;50:161&#x2013;176. doi: 10.1159/000486083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000486083</ArticleId><ArticleId IdType="pubmed">29597238</ArticleId></ArticleIdList></Reference><Reference><Citation>Tecilazich F, Formenti AM, Giustina A. Role of vitamin D in diabetic retinopathy: pathophysiological and clinical aspects. Rev. Endocr. Metab. Disord. 2021;22(4):715&#x2013;727. doi: 10.1007/s11154-020-09575-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-020-09575-4</ArticleId><ArticleId IdType="pmc">PMC7538371</ArticleId><ArticleId IdType="pubmed">33026598</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte C, Esposito A, De Lorenzo R, et al. Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: a post-hoc analysis of a prospective cohort study. Nutr. Metab. Cardiovasc Dis. 2021;31(7):2156&#x2013;2164. doi: 10.1016/j.numecd.2021.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2021.04.020</ArticleId><ArticleId IdType="pmc">PMC8091800</ArticleId><ArticleId IdType="pubmed">34059384</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo L, De Lorenzo R, Giustina A, Rovere-Querini P, Conte C. Vitamin D in osteosarcopenic obesity. Nutrients. 2022;14(9):1816. doi: 10.3390/nu14091816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14091816</ArticleId><ArticleId IdType="pmc">PMC9100750</ArticleId><ArticleId IdType="pubmed">35565781</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A. Hypovitaminosis D and the endocrine phenotype of COVID-19. Endocrine. 2021;72(1):1&#x2013;11. doi: 10.1007/s12020-021-02671-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02671-8</ArticleId><ArticleId IdType="pmc">PMC7972333</ArticleId><ArticleId IdType="pubmed">33738708</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchings N, Babalyan V, Baghdasaryan S, et al. Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D. Endocrine. 2021;71(2):267&#x2013;269. doi: 10.1007/s12020-020-02597-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02597-7</ArticleId><ArticleId IdType="pmc">PMC7811339</ArticleId><ArticleId IdType="pubmed">33452994</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Allora A, Doga M, et al. Vitamin D levels are associated with blood glucose and BMI in COVID-19 patients, predicting disease severity. J. Clin. Endocrinol. Metab. 2022;107(1):e348&#x2013;e360. doi: 10.1210/clinem/dgab599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab599</ArticleId><ArticleId IdType="pmc">PMC8385994</ArticleId><ArticleId IdType="pubmed">34383926</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulivieri FM, Banfi G, Camozzi V, et al. Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel. Endocrine. 2021;72(3):597&#x2013;603. doi: 10.1007/s12020-021-02749-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02749-3</ArticleId><ArticleId IdType="pmc">PMC8127472</ArticleId><ArticleId IdType="pubmed">33999367</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP, Formenti AM, Adler RA, et al. Vitamin D: dosing, levels, form, and route of administration: does one approach fit all? Rev. Endocr. Metab. Disord. 2021;22(4):1201&#x2013;1218. doi: 10.1007/s11154-021-09693-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09693-7</ArticleId><ArticleId IdType="pmc">PMC8696970</ArticleId><ArticleId IdType="pubmed">34940947</ArticleId></ArticleIdList></Reference><Reference><Citation>K. Shah, V.P. Varna, U. Sharma, D. Mavalankar, Does vitamin D supplementation reduce COVID-19 severity? - a systematic review [published online ahead of print, 2022 Feb 15]. QJM. 2022;hcac040. 10.1093/qjmed/hcac040</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9383458</ArticleId><ArticleId IdType="pubmed">35166850</ArticleId></ArticleIdList></Reference><Reference><Citation>S.R. Varikasuvu, B. Thangappazham, A. Vykunta, et al. COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials [published online ahead of print, 2022 Feb 3]. Expert Rev Anti Infect Ther. 2022;1&#x2013;7. 10.1080/14787210.2022.2035217</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8862170</ArticleId><ArticleId IdType="pubmed">35086394</ArticleId></ArticleIdList></Reference><Reference><Citation>Tentolouris N, Samakidou G, Eleftheriadou I, Tentolouris A, Jude EB. The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression. Diabetes Metab. Res Rev. 2022;38(4):e3517. doi: 10.1002/dmrr.3517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3517</ArticleId><ArticleId IdType="pmc">PMC9015406</ArticleId><ArticleId IdType="pubmed">34965318</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R, Banerjee M, Bhadada SK, Shetty AJ, Singh B, Vyas A. Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis. J. Endocrinol. Invest. 2022;45(1):53&#x2013;68. doi: 10.1007/s40618-021-01614-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01614-4</ArticleId><ArticleId IdType="pmc">PMC8223190</ArticleId><ArticleId IdType="pubmed">34165766</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo L, De Lorenzo R, Cinel E, et al. Weight trajectories and abdominal adiposity in COVID-19 survivors with overweight/obesity. Int J. Obes. (Lond.) 2021;45(9):1986&#x2013;1994. doi: 10.1038/s41366-021-00861-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-00861-y</ArticleId><ArticleId IdType="pmc">PMC8127478</ArticleId><ArticleId IdType="pubmed">34002039</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaton LE, Davis JK, Rawson ES, et al. Selected in-season nutritional strategies to enhance recovery for team sport athletes: a practical overview. Sports Med. 2017;47(11):2201&#x2013;2218. doi: 10.1007/s40279-017-0759-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40279-017-0759-2</ArticleId><ArticleId IdType="pmc">PMC5633631</ArticleId><ArticleId IdType="pubmed">28702900</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker T, Schneider ED, Dixon BM, Henriksen VT, Weaver LK. Supplemental vitamin D enhances the recovery in peak isometric force shortly after intense exercise. Nutr. Metab. (Lond) 2013;10(1):69. doi: 10.1186/1743-7075-10-69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-7075-10-69</ArticleId><ArticleId IdType="pmc">PMC4029611</ArticleId><ArticleId IdType="pubmed">24313936</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Hajj Fuleihan G, Nabulsi M, Tamim H, et al. Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. J. Clin. Endocrinol. Metab. 2006;91(2):405&#x2013;412. doi: 10.1210/jc.2005-1436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2005-1436</ArticleId><ArticleId IdType="pubmed">16278262</ArticleId></ArticleIdList></Reference><Reference><Citation>Haugen J, Basnet S, Hardang IM, et al. Vitamin D status is associated with treatment failure and duration of illness in Nepalese children with severe pneumonia. Pediatr. Res. 2017;82(6):986&#x2013;993. doi: 10.1038/pr.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/pr.2017.71</ArticleId><ArticleId IdType="pubmed">28678771</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero-Garc&#xed;a A, P&#xe9;rez-Valdecantos D, Guallar P, et al. Effect of vitamin D supplementation on muscle status in old patients recovering from COVID-19 infection. Med. (Kaunas) 2021;57(10):1079. doi: 10.3390/medicina57101079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57101079</ArticleId><ArticleId IdType="pmc">PMC8537350</ArticleId><ArticleId IdType="pubmed">34684116</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, McCluskey P, et al. Investigating the relationship between vitamin D and persistent symptoms following SARS-CoV-2 infection. Nutrients. 2021;13(7):2430. doi: 10.3390/nu13072430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13072430</ArticleId><ArticleId IdType="pmc">PMC8308626</ArticleId><ArticleId IdType="pubmed">34371940</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed Hussein AAR, Galal I, Amin MT, et al. Prevalence of vitamin D deficiency among patients attending Post COVID-19 follow-up clinic: a cross-sectional study. Eur. Rev. Med Pharm. Sci. 2022;26(8):3038&#x2013;3045. doi: 10.26355/eurrev_202204_28635.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202204_28635</ArticleId><ArticleId IdType="pubmed">35503606</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrea L, Grant WB, Frias-Toral E, et al. Dietary recommendations for post-COVID-19 syndrome. Nutrients. 2022;14(6):1305. doi: 10.3390/nu14061305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14061305</ArticleId><ArticleId IdType="pmc">PMC8954128</ArticleId><ArticleId IdType="pubmed">35334962</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Castellino L, Giustina A. Occurrence and response to treatment of Graves&#x2019; disease after COVID vaccination in two male patients. Endocrine. 2022;75(1):19&#x2013;21. doi: 10.1007/s12020-021-02919-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02919-3</ArticleId><ArticleId IdType="pmc">PMC8561079</ArticleId><ArticleId IdType="pubmed">34727295</ArticleId></ArticleIdList></Reference><Reference><Citation>Piec I, Cook L, Dervisevic S, et al. Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine [published online ahead of print, 2022 Mar 16] Curr. Res. Transl. Med. 2022;70(3):103344. doi: 10.1016/j.retram.2022.103344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.retram.2022.103344</ArticleId><ArticleId IdType="pmc">PMC8923881</ArticleId><ArticleId IdType="pubmed">35390564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chillon TS, Demircan K, Heller RA, et al. Relationship between vitamin D status and antibody response to COVID-19 mRNA vaccination in healthy adults. Biomedicines. 2021;9(11):1714. doi: 10.3390/biomedicines9111714.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9111714</ArticleId><ArticleId IdType="pmc">PMC8615783</ArticleId><ArticleId IdType="pubmed">34829945</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MD, Lin CH, Lei WT, et al. Does vitamin D deficiency affect the immunogenic responses to influenza vaccination? a systematic review and meta-analysis. Nutrients. 2018;10(4):409. doi: 10.3390/nu10040409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10040409</ArticleId><ArticleId IdType="pmc">PMC5946194</ArticleId><ArticleId IdType="pubmed">29587438</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalor MK, Floyd S, Gorak-Stolinska P, et al. BCG vaccination: a role for vitamin D? PLoS One. 2011;6(1):e16709. doi: 10.1371/journal.pone.0016709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0016709</ArticleId><ArticleId IdType="pmc">PMC3031626</ArticleId><ArticleId IdType="pubmed">21304967</ArticleId></ArticleIdList></Reference><Reference><Citation>Zitt E, Sprenger-M&#xe4;hr H, Knoll F, Neyer U, Lhotta K. Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease. Vaccine. 2012;30(5):931&#x2013;935. doi: 10.1016/j.vaccine.2011.11.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.11.086</ArticleId><ArticleId IdType="pubmed">22142584</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A, Bouillon R, Binkley N, et al. Controversies in vitamin D: a statement from the Third International Conference. JBMR. 2020;4(12):e10417. doi: 10.1002/jbm4.10417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbm4.10417</ArticleId><ArticleId IdType="pmc">PMC7745884</ArticleId><ArticleId IdType="pubmed">33354643</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnet JB, Berchoux E, Sultan A. Decompensated primary hypoparathyroidism in a patient with COVID-19. Ann. Endocrinol. 2021;82(2):123&#x2013;124. doi: 10.1016/j.ando.2021.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ando.2021.02.002</ArticleId><ArticleId IdType="pmc">PMC7931679</ArticleId><ArticleId IdType="pubmed">33676922</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez JL, Nan D, Fernandez-Ayala M, et al. Vitamin D status in hospitalized patients with SARS-CoV-2 infection. J. Clin. Endocrinol. Metab. 2021;106(3):e1343&#x2013;e1353. doi: 10.1210/clinem/dgaa733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa733</ArticleId><ArticleId IdType="pubmed">34932810</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazziotti G, Lavezzi E, Brunetti A, et al. Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19. J. Endocrinol. Invest. 2021;44(10):2285&#x2013;2293. doi: 10.1007/s40618-021-01535-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01535-2</ArticleId><ArticleId IdType="pmc">PMC7934807</ArticleId><ArticleId IdType="pubmed">33666876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly A, Levine MA. Hypocalcemia in the critically ill patient. J. Intensive Care Med. 2013;28(3):166&#x2013;177. doi: 10.1177/0885066611411543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066611411543</ArticleId><ArticleId IdType="pubmed">21841146</ArticleId></ArticleIdList></Reference><Reference><Citation>Krapf R, Jaeger P, Hulter HN. Chronic respiratory alkalosis induces renal PTH-resistance, hyperphosphatemia and hypocalcemia in humans. Kidney Int. 1992;42(3):727&#x2013;734. doi: 10.1038/ki.1992.340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1992.340</ArticleId><ArticleId IdType="pubmed">1405350</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y, He L, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 2004;203(2):622&#x2013;630. doi: 10.1002/path.1560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1560</ArticleId><ArticleId IdType="pmc">PMC7167761</ArticleId><ArticleId IdType="pubmed">15141376</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Ding Y, Zhang Q, et al. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J. Pathol. 2006;210(3):288&#x2013;297. doi: 10.1002/path.2067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2067</ArticleId><ArticleId IdType="pmc">PMC7167655</ArticleId><ArticleId IdType="pubmed">17031779</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkattawy S, Alyacoub R, Ayad S, Pandya M, Eckman A. A novel case of hypoparathyroidism secondary to SARS-CoV-2 infection. Cureus. 2020;12(8):e10097. doi: 10.7759/cureus.10097.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.10097</ArticleId><ArticleId IdType="pmc">PMC7522187</ArticleId><ArticleId IdType="pubmed">33005518</ArticleId></ArticleIdList></Reference><Reference><Citation>Dianatfar M, Sanjari M, Dalfardi B. Hypoparathyroidism After COVID-19 pneumonia. Magnesium. 2021;33(30-100):7.</Citation></Reference><Reference><Citation>Georgakopoulou VE, Avramopoulos P, Papalexis P, et al. COVID-19 induced hypoparathyroidism: a case report. Exp. Ther. Med. 2022;23(5):346. doi: 10.3892/etm.2022.11276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11276</ArticleId><ArticleId IdType="pmc">PMC8988155</ArticleId><ArticleId IdType="pubmed">35401797</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapani V, Rosanoff A, Baniasadi S, et al. The relevance of magnesium homeostasis in COVID-19. Eur. J. Nutr. 2022;61(2):625&#x2013;636. doi: 10.1007/s00394-021-02704-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-021-02704-y</ArticleId><ArticleId IdType="pmc">PMC8540865</ArticleId><ArticleId IdType="pubmed">34687321</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Heidari A, Johnson RH, Advani S, Petersen G. Serum magnesium levels in hospitalized patients with SARS-CoV-2. J. Investig. Med. 2022;70(2):409&#x2013;414. doi: 10.1136/jim-2021-001948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-001948</ArticleId><ArticleId IdType="pubmed">34580159</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetter T, Lohse MJ. Magnesium and the parathyroid. Curr. Opin. Nephrol. Hypertens. 2002;11(4):403&#x2013;410. doi: 10.1097/00041552-200207000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00041552-200207000-00006</ArticleId><ArticleId IdType="pubmed">12105390</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Formenti AM, Doga M, Pedone E, Rovere-Querini P, Giustina A. Radiological thoracic vertebral fractures are highly prevalent in COVID-19 and predict disease outcomes. J. Clin. Endocrinol. Metab. 2021;106(2):e602&#x2013;e614. doi: 10.1210/clinem/dgaa738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa738</ArticleId><ArticleId IdType="pmc">PMC7797741</ArticleId><ArticleId IdType="pubmed">33159451</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalava T, Sarna S, Pylkk&#xe4;nen L, et al. Association between vertebral fracture and increased mortality in osteoporotic patients. J. Bone Min. Res. 2003;18(7):1254&#x2013;1260. doi: 10.1359/jbmr.2003.18.7.1254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.2003.18.7.1254</ArticleId><ArticleId IdType="pubmed">12854835</ArticleId></ArticleIdList></Reference><Reference><Citation>Battisti S, Napoli N, Pedone C, et al. Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency. Endocrine. 2021;74(3):461&#x2013;469. doi: 10.1007/s12020-021-02872-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02872-1</ArticleId><ArticleId IdType="pmc">PMC8444515</ArticleId><ArticleId IdType="pubmed">34529239</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottlors J, Gro&#xdf;e Hokamp N, Fervers P, et al. Early extrapulmonary prognostic features in chest computed tomography in COVID-19 pneumonia: Bone mineral density is a relevant predictor for the clinical outcome - a multicenter feasibility study. Bone. 2021;144:115790. doi: 10.1016/j.bone.2020.115790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2020.115790</ArticleId><ArticleId IdType="pmc">PMC7720732</ArticleId><ArticleId IdType="pubmed">33301962</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahtabasi M, Kilicaslan N, Akin Y, et al. The prognostic value of vertebral bone density on chest CT in hospitalized COVID-19 patients. J. Clin. Densitom. 2021;24(4):506&#x2013;515. doi: 10.1016/j.jocd.2021.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2021.07.007</ArticleId><ArticleId IdType="pmc">PMC8302819</ArticleId><ArticleId IdType="pubmed">34353732</ArticleId></ArticleIdList></Reference><Reference><Citation>Napoli N, Elderkin AL, Kiel DP, Khosla S. Managing fragility fractures during the COVID-19 pandemic. Nat. Rev. Endocrinol. 2020;16(9):467&#x2013;468. doi: 10.1038/s41574-020-0379-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-0379-z</ArticleId><ArticleId IdType="pmc">PMC7288256</ArticleId><ArticleId IdType="pubmed">32528045</ArticleId></ArticleIdList></Reference><Reference><Citation>Emkey GR, Epstein S. Secondary osteoporosis: pathophysiology &amp; diagnosis. Best. Pr. Res Clin. Endocrinol. Metab. 2014;28(6):911&#x2013;935. doi: 10.1016/j.beem.2014.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2014.07.002</ArticleId><ArticleId IdType="pubmed">25432361</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazziotti G, Baracca M, Doga M, Porcelli T, Vescovi PP, Giustina A. Prevalence of thoracic vertebral fractures in hospitalized elderly patients with heart failure. Eur. J. Endocrinol. 2012;167(6):865&#x2013;872. doi: 10.1530/EJE-12-0566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-12-0566</ArticleId><ArticleId IdType="pubmed">22968484</ArticleId></ArticleIdList></Reference><Reference><Citation>S. Boussaid, Y. Makhlouf, S. Jammali, H. Sahli, M. Elleuch, S. Rekik, Association of SARS-COV2 and lumbar spine fractures: causal or coincidental? [published online ahead of print, 2021 Nov 26]. J Clin Densitom. 2021;S1094&#x2013;6950(21)00095-0. 10.1016/j.jocd.2021.11.006</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8616711</ArticleId><ArticleId IdType="pubmed">34920937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazziotti G, Bilezikian J, Canalis E, Cocchi D, Giustina A. New understanding and treatments for osteoporosis. Endocrine. 2012;41(1):58&#x2013;69. doi: 10.1007/s12020-011-9570-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-011-9570-2</ArticleId><ArticleId IdType="pubmed">22180055</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B, Kim J, Jo YH, et al. Risk of pneumonia after vertebral compression fracture in women with low bone density: a population-based study. Spine (Philos. Pa 1976) 2018;43(14):E830&#x2013;E835. doi: 10.1097/BRS.0000000000002536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000002536</ArticleId><ArticleId IdType="pubmed">29283958</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe R, Shiraki M, Saito M, Okazaki R, Inoue D. Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women. Osteoporos. Int. 2018;29(3):625&#x2013;633. doi: 10.1007/s00198-017-4337-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-017-4337-0</ArticleId><ArticleId IdType="pubmed">29218382</ArticleId></ArticleIdList></Reference><Reference><Citation>Krege JH, Kendler D, Krohn K, et al. Relationship between vertebral fracture burden, height loss, and pulmonary function in postmenopausal women with osteoporosis. J. Clin. Densitom. 2015;18(4):506&#x2013;511. doi: 10.1016/j.jocd.2015.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2015.02.004</ArticleId><ArticleId IdType="pubmed">25824332</ArticleId></ArticleIdList></Reference><Reference><Citation>L. di Filippo, N. Compagnone, S. Frara, et al. Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors [published online ahead of print, 2022 Jun 8]. Endocrine. 2022. 10.1007/s12020-022-03096-7</Citation><ArticleIdList><ArticleId IdType="pubmed">35676466</ArticleId></ArticleIdList></Reference><Reference><Citation>Formenti AM, Pedone E, di Filippo L, Ulivieri FM, Giustina A. Are women with osteoporosis treated with denosumab at risk of severe COVID-19. Endocrine. 2020;70(2):203&#x2013;205. doi: 10.1007/s12020-020-02500-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02500-4</ArticleId><ArticleId IdType="pmc">PMC7502215</ArticleId><ArticleId IdType="pubmed">32951069</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanch-Rubi&#xf3; J, Soldevila-Domenech N, T&#xed;o L, et al. Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions. Aging (Albany NY) 2020;12(20):19923&#x2013;19937. doi: 10.18632/aging.104117.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.104117</ArticleId><ArticleId IdType="pmc">PMC7655189</ArticleId><ArticleId IdType="pubmed">33080571</ArticleId></ArticleIdList></Reference><Reference><Citation>Atmaca A, Demirci I, Haymana C, et al. No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study. Osteoporos. Int. 2022;33(1):273&#x2013;282. doi: 10.1007/s00198-021-06067-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-021-06067-2</ArticleId><ArticleId IdType="pmc">PMC8369875</ArticleId><ArticleId IdType="pubmed">34402949</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsourdi E, Yu EW, Jan de Beur SM, Drake MT. Vaccination for Coronavirus Disease 2019 (COVID-19) and relationship to osteoporosis care: current evidence and suggested approaches. J. Bone Min. Res. 2021;36(6):1042&#x2013;1047. doi: 10.1002/jbmr.4304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.4304</ArticleId><ArticleId IdType="pmc">PMC8249992</ArticleId><ArticleId IdType="pubmed">33831269</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A, Marazuela M, Reincke M, Yildiz BO, Puig-Domingo M. One year of the pandemic - how European endocrinologists responded to the crisis: a statement from the European Society of Endocrinology. Eur. J. Endocrinol. 2021;185(2):C1&#x2013;C7. doi: 10.1530/EJE-21-0397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-21-0397</ArticleId><ArticleId IdType="pmc">PMC9494341</ArticleId><ArticleId IdType="pubmed">34132200</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>